UB Paderborn / Katalog / Suche / in CDI

Inflammation, non-endothelial dependent coronary microvascular function and diastolic function—Are they linked?

PloS one, 2020-07, Vol.15 (7), p.e0236035-e0236035

2020

Link zum Volltext

Verfügbarkeit prüfen

Treatment strategies in coronary microvascular dysfunction: A systematic review of interventional studies

Microcirculation (New York, N.Y. 1994), 2019-04, Vol.26 (3), p.e12430-n/a

2019

Link zum Volltext

Verfügbarkeit prüfen

Coronary Flow Velocity Reserve Assessed by Transthoracic Doppler: The iPOWER Study: Factors Influencing Feasibility and Quality

Journal of the American Society of Echocardiography, 2016-07, Vol.29 (7), p.709-716

2016

Link zum Volltext

Verfügbarkeit prüfen

Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes

The New England journal of medicine, 2023-12, Vol.389 (24), p.2221-2232

2023

Link zum Volltext

Verfügbarkeit prüfen

Coronary flow velocity reserve predicts adverse prognosis in women with angina and no obstructive coronary artery disease: results from the iPOWER study

European heart journal, 2021-01, Vol.42 (3), p.228-239

2021

Link zum Volltext

Verfügbarkeit prüfen

Impaired coronary flow velocity reserve is associated with cardiovascular risk factors but not with angina symptoms

Open heart, 2021-01, Vol.8 (1), p.e001486

2021

Link zum Volltext

Verfügbarkeit prüfen

Remote ischemic preconditioning impairs ventricular function and increases infarct size after prolonged ischemia in the isolated neonatal rabbit heart

The Journal of thoracic and cardiovascular surgery, 2014-03, Vol.147 (3), p.1049-1055

2014

Link zum Volltext

Verfügbarkeit prüfen

Effect of Liraglutide on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Polyvascular Disease: Results of the LEADER Trial

Circulation (New York, N.Y.), 2018-05, Vol.137 (20), p.2179-2183

2018

Link zum Volltext

Verfügbarkeit prüfen

Remote Preconditioning Improves Maximal Performance in Highly Trained Athletes

Medicine and science in sports and exercise, 2011-07, Vol.43 (7), p.1280-1286

2011

Link zum Volltext

Verfügbarkeit prüfen

Effect of the glucagon-like peptide-1 analogue liraglutide on coronary microvascular function in patients with type 2 diabetes - a randomized, single-blinded, cross-over pilot study

Cardiovascular diabetology, 2015-04, Vol.14 (1), p.41-41, Article 41

2015

Link zum Volltext

Verfügbarkeit prüfen

Coronary microvascular dysfunction and myocardial contractile reserve in women with angina and no obstructive coronary artery disease

Echocardiography (Mount Kisco, N.Y.), 2018-02, Vol.35 (2), p.196-203

2018

Link zum Volltext

Verfügbarkeit prüfen

Accelerated collagen turnover in women with angina pectoris without obstructive coronary artery disease: An iPOWER substudy

European journal of preventive cardiology, 2018-05, Vol.25 (7), p.719-727

2018

Link zum Volltext

Verfügbarkeit prüfen

Myocardial CT perfusion compared with transthoracic Doppler echocardiography in evaluation of the coronary microvascular function: An iPOWER substudy

Clinical physiology and functional imaging, 2021-01, Vol.41 (1), p.85-94

2021

Link zum Volltext

Verfügbarkeit prüfen

CLASSIFICATION OF CHEST PAIN COMPARED TO CORONARY FLOW RESERVE IN WOMEN WITHOUT OBSTRUCTIVE CORONARY ARTERY DISEASE

Journal of the American College of Cardiology, 2015-03, Vol.65 (10), p.A1581-A1581

2015

Link zum Volltext

Verfügbarkeit prüfen

Abstract 13814: Semaglutide Reduces Mace Consistently Across Baseline Triglyceride Levels in Patients With Type 2 Diabetes: A Post Hoc Analysis of the Sustain 6 and Pioneer 6 Trials

Circulation (New York, N.Y.), 2020-11, Vol.142 (Suppl_3 Suppl 3), p.A13814-A13814

2020

Link zum Volltext

Verfügbarkeit prüfen

Liraglutide Reduces Cardiovascular Events and Mortality in Type 2 Diabetes Mellitus Independently of Baseline Low-Density Lipoprotein Cholesterol Levels and Statin Use: Results From the LEADER Trial

Circulation (New York, N.Y.), 2018-10, Vol.138 (15), p.1605-1607

2018

Link zum Volltext

Verfügbarkeit prüfen

Liraglutide Reduces Cardiovascular Events and Mortality in Type 2 Diabetes Mellitus Independently of Baseline Low-Density Lipoprotein Cholesterol Levels and Statin Use

Circulation (New York, N.Y.), 2018-10, Vol.138 (15), p.1605-1607

2018

Link zum Volltext

Verfügbarkeit prüfen

Abstract 15094: Prevalence of Coronary Microvascular Dysfunction in Women With Angina and No Obstructive Coronary Artery Disease: Preliminary Results From the iPower Study

Circulation (New York, N.Y.), 2014-11, Vol.130 (suppl_2)

2014

Link zum Volltext

Verfügbarkeit prüfen

Abstract 13697: Glucagon-like Peptide-1 Analogue Liraglutide Does Not Improve Microvascular Myocardial Function in Patients With Type 2 Diabetes - a Randomized, Single-blinded Cross Over Trial

Circulation (New York, N.Y.), 2014-11, Vol.130 (suppl_2)

2014

Link zum Volltext

Verfügbarkeit prüfen

Abstract 13106: Exercise Tests Cannot Be Used as a Diagnostic Tool for Detection of Coronary Microvessel Dysfunction

Circulation (New York, N.Y.), 2014-11, Vol.130 (suppl_2)

2014

Link zum Volltext

Verfügbarkeit prüfen

Abstract 13781: Assessment of Microvascular Dysfunction by Transthoracic Echocardiography Compared to Positron Emission Tomography

Circulation (New York, N.Y.), 2014-11, Vol.130 (suppl_2)

2014

Link zum Volltext

Verfügbarkeit prüfen

Peripheral Reactive Hyperemia Index and Coronary Microvascular Function in Women With no Obstructive CAD

JACC. Cardiovascular imaging, 2016-04, Vol.9 (4), p.411-417

2016

Link zum Volltext

Verfügbarkeit prüfen

Abstract 17824: Self-Reported Physical Activity and Coronary Microvascular Dysfunction Are Not Associated in Women With Angina and No Obstructive Coronary Artery Disease

Circulation (New York, N.Y.), 2016-11, Vol.134 (Suppl_1 Suppl 1), p.A17824-A17824

2016

Link zum Volltext

Verfügbarkeit prüfen

Placental glucose transfer: a human in vivo study

PloS one, 2015-02, Vol.10 (2), p.e0117084-e0117084

2015

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Inflammation, non-endothelial dependent coronary microvascular function and diastolic function—Are they linked?

Treatment strategies in coronary microvascular dysfunction: A systematic review of interventional studies

Coronary Flow Velocity Reserve Assessed by Transthoracic Doppler: The iPOWER Study: Factors Influencing Feasibility and Quality

Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes

Coronary flow velocity reserve predicts adverse prognosis in women with angina and no obstructive coronary artery disease: results from the iPOWER study

Impaired coronary flow velocity reserve is associated with cardiovascular risk factors but not with angina symptoms

Remote ischemic preconditioning impairs ventricular function and increases infarct size after prolonged ischemia in the isolated neonatal rabbit heart

Effect of Liraglutide on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Polyvascular Disease: Results of the LEADER Trial

Remote Preconditioning Improves Maximal Performance in Highly Trained Athletes

Effect of the glucagon-like peptide-1 analogue liraglutide on coronary microvascular function in patients with type 2 diabetes - a randomized, single-blinded, cross-over pilot study

Coronary microvascular dysfunction and myocardial contractile reserve in women with angina and no obstructive coronary artery disease

Accelerated collagen turnover in women with angina pectoris without obstructive coronary artery disease: An iPOWER substudy

Myocardial CT perfusion compared with transthoracic Doppler echocardiography in evaluation of the coronary microvascular function: An iPOWER substudy

CLASSIFICATION OF CHEST PAIN COMPARED TO CORONARY FLOW RESERVE IN WOMEN WITHOUT OBSTRUCTIVE CORONARY ARTERY DISEASE

Abstract 13814: Semaglutide Reduces Mace Consistently Across Baseline Triglyceride Levels in Patients With Type 2 Diabetes: A Post Hoc Analysis of the Sustain 6 and Pioneer 6 Trials

Liraglutide Reduces Cardiovascular Events and Mortality in Type 2 Diabetes Mellitus Independently of Baseline Low-Density Lipoprotein Cholesterol Levels and Statin Use: Results From the LEADER Trial

Liraglutide Reduces Cardiovascular Events and Mortality in Type 2 Diabetes Mellitus Independently of Baseline Low-Density Lipoprotein Cholesterol Levels and Statin Use

Abstract 15094: Prevalence of Coronary Microvascular Dysfunction in Women With Angina and No Obstructive Coronary Artery Disease: Preliminary Results From the iPower Study

Abstract 13697: Glucagon-like Peptide-1 Analogue Liraglutide Does Not Improve Microvascular Myocardial Function in Patients With Type 2 Diabetes - a Randomized, Single-blinded Cross Over Trial

Abstract 13106: Exercise Tests Cannot Be Used as a Diagnostic Tool for Detection of Coronary Microvessel Dysfunction

Abstract 13781: Assessment of Microvascular Dysfunction by Transthoracic Echocardiography Compared to Positron Emission Tomography

Peripheral Reactive Hyperemia Index and Coronary Microvascular Function in Women With no Obstructive CAD

I m p r o ving diagnosis and treatment of w omen with angina p e ctoris and microvascular disease: The iPOWER study design and rationale

Abstract 17824: Self-Reported Physical Activity and Coronary Microvascular Dysfunction Are Not Associated in Women With Angina and No Obstructive Coronary Artery Disease

Placental glucose transfer: a human in vivo study

Suchergebnisse filtern